Characterizing PvARP, a novel Plasmodium vivax antigen

Darwin A Moreno-Pérez1, Ambar Saldarriaga, Manuel A Patarroyo

  • 1Fundación Instituto de Inmunología de Colombia (FIDIC), Carrera 50 No, 26-20, Bogotá, Colombia. mapatarr.fidic@gmail.com

Malaria Journal
|May 22, 2013
PubMed
Summary

This study characterizes the Plasmodium vivax asparagine-rich protein (PvARP), a potential target for malaria vaccines. Researchers found PvARP is expressed on merozoites and recognized by antibodies from infected individuals, indicating its role in immune response.

Related Concept Videos